Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for...
22 insider purchases on record · latest filing 2026-08-13.
Insiders have also filed 49 sale transactions at KRRO.